EP2514764
Mótefnissameindir sem binda IL-17A og IL-17F
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.10.2007EP published:
6.3.2019EP application number:
12175103.6
EP translation filed:
3.6.2019Grant published:
15.6.2019EPO information:
European Patent Register
Max expiry date:
17.10.2027Expiry date:
17.10.2026Next due date:
31.10.2026
Title:
Antibody molecules which bind IL-17A and IL-17F
Timeline
Today
18.10.2007EP application
6.3.2019EP Publication
3.6.2019Translation submitted
15.6.2019Registration published
17.10.2026Expires
Owner
Name:
UCB Biopharma SRLAddress:
Allé de la Recherche 60, 1070 Brussels, BE
Inventor
Name:
Adams, RalphAddress:
SloughBerkshire SL1 3WE, GB
Name:
Popplewell, Andrew GeorgeAddress:
SloughBerkshire SL1 3WE, GB
Name:
Rapecki, Stephen EdwardAddress:
SloughBerkshire SL1 3WE, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0620729Date:
18.10.2006Country:
GB
Classification
Categories:
C07K 16/24, A61K 39/395, C12N 15/13, A61P 37/06, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 9.9.2019
Expires: 17.10.2020
Payer: Árnason Faktor
Number: 14
Paid: 9.9.2020
Expires: 17.10.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.9.2021
Expires: 17.10.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 7.9.2022
Expires: 17.10.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 13.10.2023
Expires: 17.10.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 17.9.2024
Expires: 17.10.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 8.10.2025
Expires: 17.10.2026
Payer: Árnason Faktor ehf.